Weight Change
Conditions
Keywords
weight change, contraception, birth control, progestin, progestin only, weight gain, depo, Depo Provera, DMPA, IUD, IUC, Mirena, Paragard, Implanon, implant
Brief summary
The purpose of this study is to learn whether women who use progestin-only methods of birth control such as the contraceptive implant (Implanon), the levonorgestral-releasing IUS (Mirena), or depot medroxyprogesterone acetate(DMPA) will experience weight change compared to women using the non-hormonal copper IUC (ParaGard). The investigators primary hypothesis is that users of DMPA will gain excess weight and increase their BMI above the copper-IUC users; secondarily, the investigators will compare users' data in the LNG-IUC and ENG implant groups to the copper-IUC group.
Interventions
None listed
Sponsors
Washington University School of Medicine
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes
Inclusion criteria
* Patients enrolled in CHOICE between the ages of 18 and 45 who consented to future studies * Chose levonorgestrel-releasing IUD, copper IUD, the implant, or DMPA as their CHOICE baseline method * Has baseline height and weight data collected from the on-campus enrollment site * Able to come back to the on-campus enrollment site for consent process and enrollment activities
Exclusion criteria
* Recent history of DMPA use before starting their baseline CHOICE method * Used current method for less than 11 months or more than 12 months and three weeks
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Weight | Baseline and 12 months | Change in weight from baseline at 12 months. |
Countries
United States
Outcome results
None listed